๐ฐ Poster Sessions News
Poster Sessions News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Poster Sessions. Real-time updates on events, politics, business and more.
April 6, 2024
RAPID CITY, S.D. - South Dakota Mines is hosting its 14th annual Research Symposium on Tuesday, April 9, 2024, at the Surbeck Center in Rapid City.
November 2, 2023
/PRNewswire/ -- Dimagi, a technology partner for public and community health, will present on its innovative programs deployed across various state...
May 2, 2023
The Heart Rhythm Society Annual Meeting, HRS2023, will gather heart rhythm professionalsย from around the world when it convenes May 19-21 in New Orleans, LA.
April 6, 2023
BOSTON, April 06, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it will... | April 6, 2023
October 27, 2022
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
September 10, 2022
Durable responses to treatment, with a median duration of response (mDoR) of 11.7 months, reported in Phase 1b/2 clinical trial of onvansertib plus FO
September 8, 2022
Regulatory News: Sensorion (FR0012596468 ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent
March 31, 2022
/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its...
February 15, 2022
We are pleased to announce Psychedelic Medicine Israel - 2023, an exciting, interdisciplinary, international scientific conference that will be held in Tel Aviv on November 6 - 9, 2023.The next revolution?It is more than 60 years since the remarkable decade, when lithium, antipsychotics and antidepressants were intr...
December 10, 2021
New Data Presented at SABCS 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making Updated RxPONDER study analysis provides further evidence that the test identifies the majority of women with early-stage, node-positive breast cancer who can avoid chemotherapy...